levofloxacin has been researched along with Bacteremia in 114 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (6.14) | 18.2507 |
| 2000's | 29 (25.44) | 29.6817 |
| 2010's | 63 (55.26) | 24.3611 |
| 2020's | 15 (13.16) | 2.80 |
| Authors | Studies |
|---|---|
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Cauda, R; D'Inzeo, T; De Pascale, G; Fadda, G; Fiori, B; Leone, F; Rossi, M; Sali, M; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Fowler, VG; Luperchio, SA; McCalla, C; Moise, PA; Robinson, DA; Sakoulas, G; Smyth, DS; Steenbergen, J | 1 |
| Chang, TH; Chuang, YC; Sheng, WH; Wang, JT | 1 |
| Brackett, J; Campbell, JR; Davis, A; Foster, CE; Marquez, L; Sauer, HE; Stevens, AM | 1 |
| Chen, Y; Hu, J; Liu, J; Wang, F; Zhong, C; Zhou, H | 1 |
| Akazawa, N; Itoh, N; Kuwahara, T; Yanaidani, T | 1 |
| Chang, YT; Chen, TC; Huang, HY; Lin, SY; Lu, PL; Wang, YL; Wu, JH; Yang, TY | 1 |
| Ardura, MI; Klamer, BG; Oyeniran, SJ; Quintero, AM; Vidal, DAC | 1 |
| Hong, MY; Hsieh, CC; Ko, WC; Lee, CC; Lee, CH; Tang, HJ; Yang, CY | 1 |
| Kawabe, S; Kitajima, I; Matsui, A; Niimi, H; Noda, H; Uchiho, Y | 1 |
| Alexander, S; Ammann, RA; Beauchemin, M; Cabral, S; Carlesse, F; Castagnola, E; Davis, BL; Dupuis, LL; Egan, G; Fisher, BT; Groll, AH; Haeusler, GM; Lehrnbecher, T; Phillips, B; Robinson, PD; Santolaya, M; Steinbach, WJ; Sung, L; van de Wetering, M; Wolf, J | 1 |
| Freifeld, A; Liewer, S; Shostrom, VK; Signorelli, J; Zimmer, A | 1 |
| Bello, L; Caneiro, A; Gai, R; Galeano, S; Miller, A; Mosquera, R; Muxi, P; Oliver, AC; Pierri, S; Riva, E | 1 |
| Alexander, S; Gupta, S; Maser, B; Pelland-Marcotte, MC; Sung, L | 1 |
| Chen, G; Dong, C; Dong, Y; Fang, Y; Tao, X; Wu, S; Xu, K; Yu, Z; Zhang, L; Zhou, X; Zhu, F | 1 |
| Araoka, H; Asano-Mori, Y; Ishiwata, K; Kageyama, K; Kaji, D; Kimura, M; Mitsuki, T; Nishida, A; Ogura, S; Takagi, S; Taniguchi, S; Taya, Y; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yuasa, M | 1 |
| Myers, R; Tollkuci, E | 1 |
| Chen, L; Davidson, E; Douglass, C; Gomez-Arteaga, A; Hovan, M; Hsu, JM; Jenkins, SG; Kreiswirth, BN; La Spina, M; Malherbe, R; Mayer, S; Phillips, A; Satlin, MJ; Small, CB; Soave, R; van Besien, K; Walsh, TJ; Westblade, LF | 1 |
| Dadwal, SS; Pergam, SA | 1 |
| Balzaretti, M; Grosini, A; Piacentini, V; Poddighe, D; Pulcrano, G | 1 |
| Caliendo, G; Kim, SS; Koseck, K; Meyer, J; Steinberg, A | 1 |
| Powers, HR; Shah, K | 1 |
| Chang, CM; Hong, MY; Hung, YP; Ko, WC; Lee, CC; Lee, CH; Wang, JL | 1 |
| Flynn, PM; Gaur, AH; Hakim, H; Hayden, RT; Inaba, H; Jeha, S; Pui, CH; Stewart, T; Sun, Y; Tang, L; Wolf, J | 1 |
| Barreto, JN; Dierkhising, RA; Gangat, N; Mara, KC; Tosh, PK; Yemm, KE | 1 |
| Doi, SAR; Harris, PN; Naber, K; Roberts, MJ; Scott, S; Wagenlehner, FME | 1 |
| Fung, CP; Lin, YT; Wang, FD; Wu, PF; Yang, TC | 1 |
| Baker, TM; Chavda, KD; Chen, L; Fowler, VG; Jacobs, SE; Jenkins, SG; Kreiswirth, BN; Satlin, MJ; Schuetz, AN; Shashkina, E; Shore, TB; Small, CB; Soave, R; van Besien, K; Walsh, TJ; Westblade, LF | 1 |
| Rambaran, KA; Seifert, CF | 1 |
| Jones, BM; Keedy, C; Wynn, M | 1 |
| Alexander, S; Bailey, LC; Chen, L; Dang, H; Dvorak, CC; Fisher, B; Fisher, BT; Gaur, AH; Green, M; Nieder, ML; Sung, L; Villa Luna, D; Wiernikowski, J | 1 |
| Barrado, L; Ezpeleta-Baquedano, C; Navascués, A; Torroba-Álvarez, L | 1 |
| Bilker, W; Bink, K; Fitzpatrick, R; Gilmar, C; Gorman, T; Han, JH; Kraus, K; Kucharczuk, C; Landsburg, D; Mangan, P; Moore, A; Pegues, D; Stadtmauer, EA; Ziegler, M | 1 |
| Chen, PL; Hung, YP; Ko, WC; Lee, NY; Li, CW; Li, MC; Liu, CC; Syue, LS; Tang, HJ; Tsai, PF | 1 |
| Chen, Y; Cui, Y; Guo, P; Guo, X; Shao, S | 1 |
| Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Sakanashi, D; Shiota, A; Suematsu, H; Watanabe, H; Yamada, A; Yamagishi, Y | 1 |
| Chayakulkeeree, M; Owattanapanich, W | 1 |
| Arnold, JR; Dierkhising, RA; Narayanan, PP; Sampathkumar, P; Thurber, KM | 1 |
| Bart, G; Dernis, E; Derouet, N; Plat, M | 1 |
| Kaufman, E; Liska, D; Nandakumar, G; Rubinshteyn, V | 1 |
| Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, J; Lee, NY; Peck, KR; Song, JH | 1 |
| Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
| Audisio, E; Busca, A; De Rosa, FG; Di Perri, G; Frairia, C; Marmont, F; Motta, I | 1 |
| Boyer, MW; Goulston, C; Hanson, KE; Kim, JH; Tricot, G; Zangari, M | 1 |
| Daryanani-Daryanani, R; Estevez-Dominguez, R; Gil-Diaz, A; Gil-Reyes, J; Monzon-Moreno, C | 1 |
| Chang, J; Kim, YK; Park, YJ; Ryu, H; Yu, JK | 1 |
| Adhikary, R; Bhattacharyya, A; Bishayi, B; Mahanti, S; Majhi, A | 1 |
| Frauenfelder, T; Gerber, B; Köppel, J; Manz, MG; Nair, G; Nguyen-Kim, TD; Paul, M; Schanz, U | 1 |
| Comer, J; Kammanadiminti, S; Kodihalli, S; Meister, G; Patnaikuni, RK; Sinclair, C | 1 |
| Butler-Wu, S; Miles-Jay, A; Pergam, SA; Rowhani-Rahbar, A | 1 |
| Budzik, JF; Dehecq, E; Ducoulombier, V; Houvenagel, E; Pascart, T | 1 |
| Kurokawa, M; Nakamura, F; Nannya, Y; Shinohara, A; Taoka, K; Uni, M; Yamazaki, S; Yoshimi, A | 1 |
| Gergis, U; Jacobs, SE; Mark, TM; Satlin, MJ; Shore, TB; Soave, R; Vardhana, S; Walsh, TJ | 1 |
| Åhman, J; Kahlmeter, G; Matuschek, E; Petersen, A; Sjölund-Karlsson, M; Skov, R; Stegger, M; Torpdahl, M | 1 |
| Alonso, JM; Cantón, R; Cuartero, C; Del Campo, R; López, J; Lozano, S; Rodríguez, JD; Rodríguez-Domínguez, M; Ruiz-Garbajosa, P; Sánchez-Díaz, AM; Tedim, AP | 1 |
| Batlle Massana, M; Fernandez Sojo, J; Morgades, M; Quesada, MD; Ribera Santasusana, JM; Vives Polo, S | 1 |
| Abbassi, M; Elborai, Y; Elhaddad, A; Hafez, HA; Yousif, D | 1 |
| Chen, TL; Chiu, CH; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Wang, FD; Wang, YC; Yang, YS; Yin, T | 1 |
| Chang, FY; Chang, PY; Chao, TY; Chen, YC; Dai, MS; Ho, CL; Kao, WY; Lin, JC; Wang, CH; Wu, YY | 1 |
| Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B | 1 |
| Abe, M; Araoka, H; Asano-Mori, Y; Hishinuma, A; Ishiwata, K; Izutsu, K; Kageyama, K; Kaji, D; Kimura, M; Nishida, A; Okamoto, Y; Takagi, S; Taniguchi, S; Uchida, N; Wake, A; Yamamoto, G; Yamamoto, H; Yoneyama, A; Yoshida, A; Yuasa, M | 1 |
| Iino, N; Koda, R; Watanabe, H | 1 |
| Cho, SY; Chung, DR; Ha, YE; Kang, CI; Ko, JH; Lee, JY; Lee, NY; Lee, WJ; Park, GE; Peck, KR; Seok, HR; Song, JH | 1 |
| Joost, I; Kern, WV; Meyer, PT; Rieg, S; Steinfurt, J | 1 |
| Chatzikonstantinou, M; Galani, I; Margaritis, A; Petrikkos, G; Souli, M | 1 |
| Akahoshi, Y; Ashizawa, M; Ishihara, Y; Kako, S; Kanda, J; Kanda, Y; Kawamura, K; Kikuchi, M; Kimura, SI; Machishima, T; Nakano, H; Nakasone, H; Nishida, J; Sakamoto, K; Sato, M; Terasako-Saito, K; Ugai, T; Wada, H; Yamasaki, R; Yamazaki, R | 1 |
| Al-Hasan, MN; Albrecht, H; Bookstaver, PB; Justo, JA; Kohn, J; Shah, A | 1 |
| Abe, M; Araoka, H; Baba, M; Kimura, M; Okada, C; Yoneyama, A | 1 |
| Chan, YJ; Huang, YC; Huang, YW; Lin, YT; Wang, FD; Yang, TC | 1 |
| Görümlü, G; Işikgoz Taşbakan, M; Karabulut, B; Pullukçu, H; Sanli, UA; Sipahi, OR; Tünger, A | 1 |
| Bellon, A; Chacko, RC; Coverdale, JH; Perez-Garcia, G | 1 |
| Corey, L; Fredricks, DN; Frieze, D; Guthrie, KA; Yong, M | 1 |
| Blau, IW; Schmidt-Hieber, M; Stroux, A; Thiel, E | 1 |
| Otuk, G; Ozbek, B | 1 |
| Chi, CL; Chuang, TY; Hsueh, PR; Lee, SW; Lin, CJ; Lin, TL; Liu, AY; Wang, JT | 1 |
| Dien Bard, J; Humphries, R; Kelesidis, T; Lewinski, MA; Uslan, DZ; Ward, K | 1 |
| Aggarwal, H; Conti, D; Gallichio, M; Kushnir, L; Tobin, E | 1 |
| Chen, PM; Chen, TL; Chiou, TJ; Gau, JP; Hsiao, LT; Huang, LJ; Lai, YC; Liu, CY; Liu, JH; Tzeng, CH; Yang, YW | 1 |
| Aracil, B; Campos, J; Cuevas, O; de Abajo, F; García-Cobos, S; Lázaro, E; Ortega, A; Oteo, J | 1 |
| Dyer, DN; Hatkin, JM; Orr, SA; Pitt, ML; Yee, SB | 1 |
| Barr, EB; Brasel, TL; Gigliotti, AP; Koster, F; Layton, RC; McDonald, JD; Mega, W | 1 |
| Baldi, I; Busca, A; Cavecchia, I; Ciccone, G; D'Ardia, S; De Rosa, FG; Falda, M; Gaido, E; Locatelli, F; Marmont, F; Serra, R | 1 |
| Goto, H; Higaki, M; Honda, K; Ishii, H; Mikura, S; Nakamura, M; Okazaki, M; Tsunoda, T; Wada, H; Watanabe, T; Yasutake, T | 1 |
| Feldman, L; Franco, M; Passerini de Rossi, B; Pineda, MS; Vay, C | 1 |
| Bru, JP | 1 |
| Gradon, JD; Smith, MD | 1 |
| Elliott, MA; Patel, R; Prabhu, RM | 1 |
| Akins, RL; Davis, WR; Gopalachar, A; Siddiqui, AA | 1 |
| Allione, B; Amadori, S; Bucaneve, G; Buelli, M; Cantaffa, R; Cilloni, D; D'Antonio, D; Del Favero, A; Deliliers, GL; Dionisi, MS; Fabbiano, F; Foà, R; Lauria, F; Martinelli, G; Martino, P; Menichetti, F; Micozzi, A; Nosari, AM; Specchia, G; Zuffa, E | 1 |
| Ho, PL; Lau, SK; Mak, GC; Tse, CW; Wong, SS | 1 |
| Järvinen, A; Kauma, H; Koivula, I; Kotilainen, P; Lumio, J; Nikoskelainen, J; Rintala, E; Ruotsalainen, E; Vaara, M; Valtonen, V | 1 |
| Kahn, JB; Khashab, MM; Shorr, AF; Tennenberg, AM; Xiang, JX | 1 |
| Bommer, M; Döhner, H; Kern, P; Kern, WV; Marre, R; Reuter, S; Sigge, A; von Baum, H | 1 |
| Cambau, E; Cattoir, V; Denamur, E; Lascols, C; Legrand, P; Lesprit, P; Soussy, CJ | 1 |
| Benzonana, NA; Ozer, S; Oznur, AK | 1 |
| Chima, CO; Fulton, KB; Pound, MW | 1 |
| Craig, M; Cumpston, AD; Devetten, MP; Ericson, SG; Hobbs, GR; Sarwari, AR | 1 |
| Chang, CY; Lee, YT; Liu, KS; Tsao, SM; Wang, YL | 1 |
| de Cueto, M; López-Cerero, L; Pascual, A; Rodríguez, JM; Soriano, MJ; Venero, J | 1 |
| Plouffe, JF | 1 |
| Bermudez, LE; Kolonoski, P; Young, LS | 1 |
| Amaratunga, DJ; Barrett, JF; Frosco, MB; Yagel, SK | 1 |
| Furuya, N; Iwata, M; Matsumoto, T; Mizuiri, S; Tateda, K; Yamaguchi, K | 1 |
| Bui, KQ; Nicolau, DP; Nightingale, CH; Onyeji, CO; Owens, RC; Quintiliani, R | 1 |
| Hooper, CJ; Limaye, AP | 1 |
| Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M | 1 |
| Bush, K; Fogarty, C; Goldschmidt, R | 1 |
| Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S | 1 |
| Appelbaum, PC; Credito, KL; Jacobs, MR | 1 |
| Crawford, S; Jorgensen, JH; McElmeel, ML; Murray, CK; Walter, EA | 1 |
| Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I | 1 |
| Khaliq, Y; Litzow, MR; Patel, R; Piper, KE; Razonable, RR; Rouse, MS | 1 |
| Gorbach, SL; Ross, JJ; Worthington, MG | 1 |
12 review(s) available for levofloxacin and Bacteremia
| Article | Year |
|---|---|
Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Child; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Neoplasms | 2020 |
First report of Kocuria marina bloodstream infection unrelated to a central venous catheter: a mini-review on an emerging and under-recognized opportunistic pathogen.
Topics: Anti-Bacterial Agents; Asthma; Bacteremia; Body Mass Index; Central Venous Catheters; Female; Gram-Positive Bacterial Infections; Humans; Leg Ulcer; Levofloxacin; Micrococcaceae; Middle Aged; Risk Factors; Smoking; Treatment Outcome | 2017 |
Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Biopsy, Large-Core Needle; Ciprofloxacin; Fluoroquinolones; Fosfomycin; Humans; Image-Guided Biopsy; Levofloxacin; Male; Middle Aged; Prostate; Sepsis; Ultrasonography; Urinary Tract Infections | 2018 |
Clostridium colicanis bacteraemia in an asthmatic patient diagnosed as acute respiratory infection.
Topics: Aged; Anti-Bacterial Agents; Asthma; Bacteremia; Cefotaxime; Clostridium; Clostridium Infections; Diagnostic Errors; Drug Therapy, Combination; Female; Humans; Immunocompetence; Levofloxacin; Respiratory Tract Infections | 2019 |
Roseomonas mucosa infective endocarditis in patient with systemic lupus erythematosus: case report and review of literature.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Endocarditis; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Lupus Erythematosus, Systemic; Methylobacteriaceae; Piperacillin, Tazobactam Drug Combination | 2019 |
Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacteremia; Bile Ducts; Cholangitis; Enterobacteriaceae Infections; Female; Humans; Immunocompetence; Immunocompromised Host; Levofloxacin; Meropenem; Pantoea | 2019 |
Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
Topics: Acute Disease; Bacteremia; Febrile Neutropenia; Female; Humans; Leukemia; Levofloxacin; Male | 2019 |
[Post-partum infectious sacroiliitis].
Topics: Adult; Bacteremia; Drug Therapy, Combination; Emergencies; Female; Humans; Levofloxacin; Magnetic Resonance Imaging; Pregnancy; Psoas Abscess; Puerperal Disorders; Rifampin; Sacroiliitis; Staphylococcal Infections | 2013 |
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection | 2017 |
Seizures associated with levofloxacin: case presentation and literature review.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cytochrome P-450 CYP1A2; Dopamine Antagonists; Drug Administration Schedule; Drug Synergism; Female; Humans; Klebsiella Infections; Levofloxacin; Male; Metoclopramide; Mianserin; Middle Aged; Mirtazapine; Ofloxacin; Phosphodiesterase Inhibitors; Seizures; Theophylline | 2009 |
Bacteremia due to Comamonas species possibly associated with exposure to tropical fish.
Topics: Administration, Oral; Aged; Aged, 80 and over; Animals; Animals, Domestic; Anti-Infective Agents; Bacteremia; Causality; Comamonas; Diagnosis, Differential; Drug Resistance; Environmental Exposure; Fever; Fish Diseases; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pharyngitis; Tomography, X-Ray Computed; Treatment Outcome; Zoonoses | 2003 |
Treatment of tularemia with fluoroquinolones: two cases and review.
Topics: Adult; Anti-Infective Agents; Bacteremia; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Tularemia | 1999 |
11 trial(s) available for levofloxacin and Bacteremia
| Article | Year |
|---|---|
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Daptomycin; Endocarditis, Bacterial; Genotype; Hemolysin Proteins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Child; Child, Preschool; Clostridium Infections; Cohort Studies; Drug Resistance, Microbial; Female; Humans; Induction Chemotherapy; Levofloxacin; Logistic Models; Male; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2017 |
Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Child; Child, Preschool; Female; Hematopoietic Stem Cell Transplantation; Humans; Infant; Leukemia, Myeloid, Acute; Levofloxacin; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Young Adult | 2018 |
Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis.
Topics: Adult; Aged; Allografts; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Female; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Gram-Negative Bacterial Infections; Humans; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Time Factors | 2015 |
Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.
Topics: Acute Disease; Adolescent; Adult; Aged; Allografts; Anti-Bacterial Agents; Bacteremia; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies | 2017 |
Antibacterial prophylaxis with levofloxacin in patients after allogeneic stem cell transplantation and neutrophil reconstitution: results from a double-blinded, placebo-controlled phase III trial and overview of recent clinical practice.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Double-Blind Method; Female; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Myelodysplastic Syndromes; Neutrophils; Ofloxacin; Placebos; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome | 2010 |
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Bacterial Infections; Double-Blind Method; Female; Fever of Unknown Origin; Humans; Levofloxacin; Logistic Models; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Risk | 2005 |
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Drug Therapy, Combination; Female; Finland; Humans; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Penicillins; Prospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure | 2006 |
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Drug Administration Schedule; Hospitalization; Humans; Levofloxacin; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2006 |
The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Neutropenia; Ofloxacin; Retrospective Studies; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous | 2007 |
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins | 1999 |
91 other study(ies) available for levofloxacin and Bacteremia
| Article | Year |
|---|---|
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Risk Factors; Treatment Failure | 2008 |
Clinical characteristics and outcomes of non-cystic fibrosis patients with Burkholderia cepacia complex bacteremia at a medical center in Taiwan.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Fibrosis; Hospitals; Humans; Levofloxacin; Retrospective Studies; Taiwan; Trimethoprim | 2022 |
Levofloxacin prophylaxis for pediatric leukemia patients: Longitudinal follow-up for impact on health care-associated infections.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Child; Clostridioides difficile; Cross Infection; Delivery of Health Care; Diarrhea; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Retrospective Studies; Sepsis | 2022 |
Bacteremia caused by accidental injection of Bacillus licheniformis microbiota modulator through the central venous catheter: A case report.
Topics: Aged; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus licheniformis; Bacteremia; Central Venous Catheters; Female; Humans; Levofloxacin; Medical Errors; Microbiota; Vancomycin | 2022 |
Clinical and microbiological features of intratumor abscess with bloodstream infection caused by Plesiomonas shigelloides, Citrobacter freundii, Streptococcus mitis/oralis, Clostridium perfringens, and Candida albicans in a patient with cholangiocarcinoma
Topics: Abscess; Aged; Antifungal Agents; Bacteremia; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Candida albicans; Cholangiocarcinoma; Citrobacter freundii; Clostridium perfringens; Humans; Levofloxacin; Male; Piperacillin; Plesiomonas; RNA, Ribosomal, 16S; Sepsis; Soil; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptococcus mitis; Streptococcus oralis; Tazobactam | 2022 |
Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.
Topics: Agar; Anti-Bacterial Agents; Bacteremia; Humans; Levofloxacin; Microbial Sensitivity Tests | 2022 |
Emerging Resistance Trends in Viridans Group Streptococci Bloodstream Infections Among Immunocompromised Children Receiving Levofloxacin Prophylaxis.
Topics: Anti-Bacterial Agents; Bacteremia; Child; Humans; Levofloxacin; Microbial Sensitivity Tests; Streptococcal Infections; Viridans Streptococci | 2023 |
Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Community-Acquired Infections; Comorbidity; Enterobacteriaceae Infections; Female; Humans; Length of Stay; Levofloxacin; Male; Neoplasms; Retrospective Studies | 2019 |
A Rapid ATP Bioluminescence-based Test for Detecting Levofloxacin Resistance Starting from Positive Blood Culture Bottles.
Topics: Adenosine Triphosphate; Anti-Bacterial Agents; Bacteremia; Blood Culture; Drug Resistance, Bacterial; Humans; Levofloxacin; Luminescent Measurements; Microbial Sensitivity Tests; Pilot Projects | 2019 |
Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Retrospective Studies; Transplant Recipients; Transplantation, Autologous; Transplantation, Homologous | 2020 |
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Topics: Adolescent; Adult; Aged; Amikacin; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Ceftazidime; Ciprofloxacin; Febrile Neutropenia; Female; Fever of Unknown Origin; Hematologic Neoplasms; Humans; Incidence; Levofloxacin; Male; Meropenem; Middle Aged; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation, Autologous; Uruguay; Young Adult | 2020 |
Levofloxacin prophylaxis in hospitalized children with leukemia: A cost-utility analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Child; Cost-Benefit Analysis; Follow-Up Studies; Hospitalization; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Quality-Adjusted Life Years | 2020 |
Vogesella perlucida-induced bacteremia in an advanced-age patient: first case report.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Betaproteobacteria; Female; Humans; Levofloxacin; RNA, Ribosomal, 16S; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2020 |
Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies; Transplant Recipients; Young Adult | 2021 |
Topics: Bacteremia; Catheterization, Central Venous; Citrobacter; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Retrospective Studies | 2021 |
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Retrospective Studies; Transplant Recipients | 2021 |
Can a Simple Stool Swab Predict Bacteremia in High-Risk Hematopoietic Cell Transplant Recipients?
Topics: Bacteremia; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Transplant Recipients | 2021 |
Comparison of the rates of Clostridium difficile and bacteremia after delaying fluoroquinolone prophylaxis from day 0 to day +3 post autologous stem cell transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridioides difficile; Clostridium Infections; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Transplantation, Autologous; Young Adult | 2017 |
Bordetella bronchiseptica bloodstream infection in a renal transplant patient.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Biopsy; Bordetella bronchiseptica; Bordetella Infections; Dogs; Humans; Immunocompromised Host; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Levofloxacin; Male; Middle Aged; Skin; Skin Neoplasms | 2017 |
Age-Related Trends in Adults with Community-Onset Bacteremia.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Aging; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Community-Acquired Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Proteus mirabilis; Retrospective Studies; Young Adult | 2017 |
A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Bacteremia; Cephalosporins; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Leukemia; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult | 2018 |
Is fluoroquinolone monotherapy a useful alternative treatment for Pseudomonas aeruginosa bacteraemia?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ciprofloxacin; Cohort Studies; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Taiwan; Treatment Outcome | 2018 |
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gastrointestinal Tract; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Neutropenia; Prospective Studies; Risk Factors | 2018 |
Ciprofloxacin vs. levofloxacin for prophylaxis in recipients of hematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Female; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Young Adult | 2019 |
Successful treatment of Enterococcus faecalis bacteremia with dalbavancin as an outpatient in an intravenous drug user.
Topics: Adult; Bacteremia; Blood Culture; Catheterization, Central Venous; Enterococcus faecalis; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Outpatients; Substance Abuse, Intravenous; Teicoplanin | 2018 |
Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Clostridium Infections; Febrile Neutropenia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infection Control; Infections; Levofloxacin; Male; Middle Aged; Sepsis; Transplantation, Autologous | 2019 |
Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Candidemia; Cefepime; Coinfection; Dengue; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcus; Taiwan | 2019 |
Comparison of intravenous and oral definitive antibiotic regimens in hospitalised patients with Gram-negative bacteraemia from a urinary tract infection.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Female; Gram-Negative Bacteria; Humans; Kaplan-Meier Estimate; Length of Stay; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Failure; Urinary Tract Infections | 2019 |
Clostridium difficile bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Clostridioides difficile; Clostridium Infections; Humans; Intestinal Perforation; Levofloxacin; Lymphoma, Mantle-Cell; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2013 |
Can levofloxacin be a useful alternative to trimethoprim-sulfamethoxazole for treating Stenotrophomonas maltophilia bacteremia?
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Stenotrophomonas maltophilia; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Bacteria; Bacterial Infections; Ciprofloxacin; Female; Fluoroquinolones; Humans; Incidence; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2013 |
Impact of a change in antibacterial prophylaxis on bacteremia and hospitalization rates following outpatient autologous peripheral blood stem cell transplantation for multiple myeloma.
Topics: Aged; Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Levofloxacin; Male; Middle Aged; Multiple Myeloma; Outpatients; Peripheral Blood Stem Cell Transplantation; Retrospective Studies | 2014 |
Fever of unknown origin in a young man.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Community-Acquired Infections; Fever; Fever of Unknown Origin; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Levofloxacin; Male; Sphingomonas | 2014 |
Dominance of clonal complex 10 among the levofloxacin-resistant Streptococcus agalactiae isolated from bacteremic patients in a Korean hospital.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Multilocus Sequence Typing; Republic of Korea; Streptococcal Infections; Streptococcus agalactiae; Young Adult | 2014 |
Levofloxacin-ceftriaxone combination attenuates lung inflammation in a mouse model of bacteremic pneumonia caused by multidrug-resistant Streptococcus pneumoniae via inhibition of cytolytic activities of pneumolysin and autolysin.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Bronchoalveolar Lavage Fluid; Ceftriaxone; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Levofloxacin; Male; Mice; Mice, Inbred BALB C; N-Acetylmuramoyl-L-alanine Amidase; Pneumococcal Infections; Pneumonia; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Streptolysins; Virulence; Virulence Factors | 2014 |
Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Agents; Bacteremia; Disease-Free Survival; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Mycoses; Retrospective Studies; Survival Rate; Triazoles | 2014 |
Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Disease Models, Animal; Drug Therapy, Combination; Female; Immunoglobulins, Intravenous; Levofloxacin; Male; Rabbits; Respiratory Tract Infections; Toxemia; Treatment Outcome | 2014 |
Spondylodiscitis due to Rhizobium radiobacter.
Topics: Aged, 80 and over; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Catheter-Related Infections; Catheterization, Central Venous; Discitis; Drug Resistance, Multiple, Bacterial; Environmental Exposure; Female; Gram-Negative Bacterial Infections; Heart Failure; Humans; Immunocompromised Host; Levofloxacin; Lumbar Vertebrae; Lymphoma, Follicular; Rituximab; Tomography, X-Ray Computed | 2015 |
Comparison of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia.
Topics: Adult; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacterial Infections; Febrile Neutropenia; Female; Fluoroquinolones; Humans; Leukemia, Myeloid, Acute; Levofloxacin; Male; Middle Aged; Primary Prevention; Retrospective Studies; Sample Size | 2015 |
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Female; Filgrastim; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Levofloxacin; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous | 2015 |
Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
Topics: Anti-Bacterial Agents; Bacteremia; Base Sequence; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Nalidixic Acid; Ofloxacin; Pefloxacin; Salmonella enterica; Salmonella Infections; Sequence Analysis, DNA | 2015 |
The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; beta-Lactam Resistance; Blood; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Levofloxacin; Male; Middle Aged; Molecular Typing; Neutropenia; Prospective Studies; Real-Time Polymerase Chain Reaction; Risk Assessment | 2016 |
[Comparative study on the usefulness of antibacterial prophylaxis with levofloxacin in patients submitted to hematopoietic stem cell transplantation].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Female; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2016 |
Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation.
Topics: Adolescent; Antibiotic Prophylaxis; Bacteremia; Child; Child, Preschool; Febrile Neutropenia; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Hematopoietic Stem Cell Transplantation; Humans; Infant; Levofloxacin; Male; Prognosis; Risk Factors; Transplantation, Autologous | 2015 |
A retrospective study of the incidence, clinical characteristics, identification, and antimicrobial susceptibility of bacteremic isolates of Acinetobacter ursingii.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Ceftazidime; Ceftriaxone; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Incidence; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Retrospective Studies; RNA, Ribosomal, 16S | 2015 |
Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Drug Resistance, Multiple, Bacterial; Female; Graft vs Host Disease; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Retrospective Studies; Risk Factors; Taiwan; Transplant Recipients; Transplantation Conditioning; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Young Adult | 2018 |
Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hospitals; Humans; Japan; Levofloxacin; Male; Middle Aged; Retrospective Studies; Streptococcal Infections; Transplantation Conditioning; Transplantation, Homologous; Viridans Streptococci; Young Adult | 2016 |
Mycotic Aneurysm of the Abdominal Aorta Complicated With Iliopsoas Abscess and Infectious Spondylodiscitis in a Long-Term Hemodialyzed Patient: A Rare but Serious Complication of Staphylococcus Aureus Bacteremia.
Topics: Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Bacteremia; Cefazolin; Ceftriaxone; Discitis; Drainage; Humans; Levofloxacin; Male; Middle Aged; Psoas Abscess; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus | 2016 |
Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Topics: Acinetobacter baumannii; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunosuppressive Agents; Intensive Care Units; Length of Stay; Levofloxacin; Male; Middle Aged; Neutropenia; Pseudomonas aeruginosa; Respiratory Tract Infections; Risk Factors; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab.
Topics: Administration, Intravenous; Administration, Oral; Arthritis, Psoriatic; Bacteremia; Dermatologic Agents; Endarteritis; Female; Floxacillin; Humans; Iliac Artery; Levofloxacin; Middle Aged; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Ustekinumab | 2016 |
Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gram-Negative Bacterial Infections; Greece; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Quinolones; R Factors; Stenotrophomonas maltophilia | 2017 |
Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Pyelonephritis; Urinary Tract Infections | 2017 |
Evaluation of trimethoprim-sulfamethoxazole based combination therapy against Stenotrophomonas maltophilia: in vitro effects and clinical efficacy in cancer patients.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Clavulanic Acids; Drug Therapy, Combination; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Minocycline; Neoplasms; Stenotrophomonas maltophilia; Ticarcillin; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2017 |
Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; Chryseobacterium; Drug Resistance, Bacterial; Female; Flavobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Survival Analysis; Taiwan; Treatment Outcome | 2017 |
[A rare cause of catheter-related bacteremia: Rhizobium radiobacter].
Topics: Adult; Agrobacterium tumefaciens; Anti-Bacterial Agents; Bacteremia; Bone Neoplasms; Catheterization, Central Venous; Catheters, Indwelling; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Osteosarcoma | 2008 |
The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bacteremia; Ceftazidime; Disease-Free Survival; Drug Resistance, Bacterial; Female; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Retrospective Studies; Transplantation Conditioning; Young Adult | 2010 |
Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Time Factors; Tobramycin | 2009 |
Rapidly fatal bacteremic pneumonia caused by Klebsiella pneumoniae with K1 hypermucoviscosity phenotype in a previously healthy young man receiving levofloxacin treatment.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacteremia; Bacterial Capsules; Bacterial Typing Techniques; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Multiple Organ Failure; Ofloxacin; Phenotype; Pneumonia, Bacterial; Polysaccharides, Bacterial; Serotyping; Shock, Septic; Young Adult | 2009 |
First report of treatment of Anaerobiospirillum succiniciproducens bloodstream infection with levofloxacin.
Topics: Aged, 80 and over; Anaerobiospirillum; Anti-Bacterial Agents; Bacteremia; DNA, Bacterial; DNA, Ribosomal; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Male; Microscopy; Microscopy, Electron, Transmission; Ofloxacin; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2010 |
A case of Campylobacter jejuni bacteremia in a renal transplant patient.
Topics: Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Diarrhea; Female; Humans; Immunocompromised Host; Kidney Transplantation; Levofloxacin; Middle Aged; Ofloxacin; Treatment Outcome | 2010 |
Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Cohort Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Kaplan-Meier Estimate; Levofloxacin; Male; Ofloxacin; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Young Adult | 2011 |
Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin/clavulanic acid.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Aza Compounds; Bacteremia; Drug Resistance, Bacterial; Drug Utilization; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Spain; Young Adult | 2011 |
Aerosolized Bacillus anthracis infection in New Zealand white rabbits: natural history and intravenous levofloxacin treatment.
Topics: Aerosols; Animals; Anthrax; Anti-Bacterial Agents; Antigens, Bacterial; Bacillus anthracis; Bacteremia; Biomarkers; Female; Levofloxacin; Male; Ofloxacin; Rabbits; Spores, Bacterial; Time Factors | 2010 |
Levofloxacin cures experimental pneumonic plague in African green monkeys.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Chlorocebus aethiops; Disease Models, Animal; Infusions, Intravenous; Levofloxacin; Lung; Ofloxacin; Plague; Primate Diseases; Radiography, Thoracic; Survival Analysis | 2011 |
Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Candida; Candida albicans; Candidemia; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Levofloxacin; Male; Middle Aged; Ofloxacin; Transplantation, Homologous; Young Adult | 2012 |
Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Humans; Imipenem; Infant; Infant, Newborn; Levofloxacin; Male; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Young Adult | 2011 |
Comparative in vitro efficacies of ethanol-, EDTA- and levofloxacin-based catheter lock solutions on eradication of Stenotrophomonas maltophilia biofilms.
Topics: Anti-Bacterial Agents; Argentina; Bacteremia; Biofilms; Catheter-Related Infections; Catheters, Indwelling; Chelating Agents; Colony Count, Microbial; Edetic Acid; Ethanol; Hospitals, University; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Solutions; Stenotrophomonas maltophilia | 2012 |
[Update on the role of levofloxacin in the management of acute community-acquired pneumonia].
Topics: Acute Disease; Anti-Infective Agents; Bacteremia; Community-Acquired Infections; Humans; Levofloxacin; Ofloxacin; Pneumonia; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
Apparent failure of moxifloxacin to prevent ciprofloxacin- and levofloxacin-susceptible Pseudomonas aeruginosa bacteremia in neutropenic patients undergoing peripheral blood stem cell transplantation.
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Female; Fluoroquinolones; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Neutropenia; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Treatment Failure | 2004 |
Urinary tract infection caused by Aerococcus viridans, a case report.
Topics: Aged; Aged, 80 and over; Bacteremia; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Ofloxacin; Streptococcaceae; Urinary Tract Infections | 2004 |
Reduced levofloxacin susceptibility and tetracycline resistance in a clinical isolate of Haemophilus quentini identified by 16S rRNA sequencing.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Haemophilus; Haemophilus Infections; Humans; Infant, Newborn; Levofloxacin; Nalidixic Acid; Ofloxacin; Phenotype; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tetracycline Resistance | 2005 |
Moxifloxacin prophylaxis in neutropenic patients.
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Aza Compounds; Bacteremia; Clostridioides difficile; Enterocolitis, Pseudomembranous; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Moxifloxacin; Neutropenia; Ofloxacin; Quinolines | 2006 |
In vivo selection during ofloxacin therapy of Escherichia coli with combined topoisomerase mutations that confer high resistance to ofloxacin but susceptibility to nalidixic acid.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Topoisomerases; Drug Resistance; Escherichia coli; Escherichia coli Infections; Humans; Levofloxacin; Male; Nalidixic Acid; Ofloxacin | 2006 |
[Antibiotic resistance in Streptococcus pneumoniae strains isolated from sterile body sites].
Topics: Anti-Bacterial Agents; Bacteremia; Cerebrospinal Fluid; Dacryocystitis; Drug Resistance, Bacterial; Ear, Middle; Erythromycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Pleural Effusion; Pneumococcal Infections; Streptococcus pneumoniae; Synovial Fluid; Wound Infection | 2006 |
Successful treatment of Klebsiella rhinoscleromatis bacteremia with levofloxacin.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Ofloxacin | 2007 |
Chromobacterium violaceum infection in Taiwan: a case report and literature review.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Chromobacterium; Female; Gram-Negative Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Taiwan; Wound Infection | 2007 |
Fatal levofloxacin failure in treatment of a bacteremic patient infected with Streptococcus pneumoniae with a preexisting parC mutation.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Fatal Outcome; Humans; Levofloxacin; Male; Mutation; Ofloxacin; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Failure | 2008 |
Levofloxacin in vitro activity against bacteremic isolates of Streptococcus pneumoniae. Franklin County Pneumonia Study Group.
Topics: Anti-Infective Agents; Bacteremia; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus pneumoniae | 1996 |
Roxithromycin alone and in combination with either ethambutol or levofloxacin for disseminated Mycobacterium avium infections in beige mice.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; Bacteremia; Colony Count, Microbial; Drug Combinations; Ethambutol; Levofloxacin; Mice; Mycobacterium avium; Ofloxacin; Roxithromycin; Spleen; Tuberculosis | 1996 |
In vivo oral efficacy of levofloxacin for treatment of systemic Pseudomonas aeruginosa infections in a murine model of septicemia.
Topics: Administration, Oral; Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Female; Levofloxacin; Mice; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 1996 |
Primary Shewanella alga septicemia in a patient on hemodialysis.
Topics: Anti-Bacterial Agents; Bacteremia; Cefazolin; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Negative Facultatively Anaerobic Rods; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Renal Dialysis | 1999 |
Comparative efficacies of levofloxacin and ciprofloxacin against Streptococcus pneumoniae in a mouse model of experimental septicaemia.
Topics: Acute Kidney Injury; Administration, Cutaneous; Animals; Anti-Infective Agents; Bacteremia; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Microbial; Humans; Lethal Dose 50; Levofloxacin; Mice; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Survival Analysis; Time Factors; Uranyl Nitrate | 1999 |
Bacteremic pneumonia due to multidrug-resistant pneumococci in 3 patients treated unsuccessfully with azithromycin and successfully with levofloxacin.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteremia; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine | 2000 |
Anti-anaerobic activity of levofloxacin alone and combined with clindamycin and metronidazole.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteria, Anaerobic; Clindamycin; Drug Combinations; Drug Synergism; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 2000 |
Abiotrophia bacteremia in a patient with neutropenic fever and antimicrobial susceptibility testing of Abiotrophia isolates.
Topics: Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Drug Resistance, Microbial; Fever; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcaceae | 2001 |
[In vitro activity of six fluoroquinolones and penicillin against 101 viridans group streptococci characterized by their susceptibility to erythromycin].
Topics: Anti-Infective Agents; Aza Compounds; Bacteremia; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Norfloxacin; Ofloxacin; Penicillins; Quinolines; Streptococcal Infections; Streptococcus | 2001 |
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis.
Topics: Adult; Aged; Anti-Infective Agents; Bacteremia; Chemoprevention; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Ofloxacin; Streptococcus | 2002 |
Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
Topics: Aged; Anti-Infective Agents; Bacteremia; Drug Resistance, Bacterial; Fatal Outcome; Humans; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Treatment Failure | 2002 |